ClinicalTrials.Veeva

Menu

Survivor-Sleep Health Information Program

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Completed

Conditions

Sleep Problem
Insomnia
Pediatric Cancer

Treatments

Behavioral: Survivor-SHIP

Study type

Interventional

Funder types

Other

Identifiers

NCT04863157
21-018 (Other Identifier)

Details and patient eligibility

About

The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

Full description

This study will evaluate Survivor-SHIP in a single-arm trial of 20 off-treatment childhood cancer survivors (ages 5-12). The intervention is an adapted version of the family-centered Sleep Health Program designed at Seattle Children's Hospital. The program offers parents information about how to utilize evidence-based strategies for their child's sleep, and has demonstrated success in a community-based sample of children with behavioral sleep problems. Sessions will focus on providing parents with education about healthy sleep and setting targets for modifiable behaviors that can improve their child's sleep health.

The study will include 3 education sessions taking place over videoconference. Families will be asked to track their child's sleep using sleep diaries during the course of the program. Prior to, and following the program, families will be asked to complete study questionnaires.

Enrollment

16 patients

Sex

All

Ages

5 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Child aged 5-12 years, with a history of a cancer diagnosis (except non-melanoma skin cancer).
  • No cancer therapy (excluding chemoprevention) in the past 6 months, and no further therapy planned.
  • Child meets diagnostic criteria for insomnia disorder as determined by insomnia screening criteria (see Appendix A)
  • Parent/guardian is able to read and write in English.
  • Regular access to a computer/smartphone with internet access at home.

Exclusion criteria

  • Reports child has been diagnosed with a Seizure Disorder or has experienced a seizure in the past 12 months.
  • Reports child has been diagnosed with a developmental disorder such as Autism Spectrum Disorder, Cerebral Palsy, Fragile X Syndrome, or Moderate to Profound Intellectual Disability.
  • Reports child has been diagnosed with sleep apnea, and are not receiving recommended medical treatment for their sleep apnea.
  • Intention to adjust (decrease or increase) child's use of any prescribed or over-the-counter sleep medications during the study period.
  • Any impairment (e.g., hearing, visual, cognitive) that interferes with the parent/guardian's ability to complete all study procedures independently.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

Survivor-SHIP
Experimental group
Description:
Parents/guardians will take part in 3 education sessions over a one month period. During the sessions, they will learn more about common sleep problems following cancer treatment and ways to understand their child's unique patterns. They will then be educated about behavioral changes they can make to improve their child's sleep.
Treatment:
Behavioral: Survivor-SHIP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems